207 related articles for article (PubMed ID: 30044983)
1. Conservation of Structure and Immune Antagonist Functions of Filoviral VP35 Homologs Present in Microbat Genomes.
Edwards MR; Liu H; Shabman RS; Ginell GM; Luthra P; Ramanan P; Keefe LJ; Köllner B; Amarasinghe GK; Taylor DJ; Leung DW; Basler CF
Cell Rep; 2018 Jul; 24(4):861-872.e6. PubMed ID: 30044983
[TBL] [Abstract][Full Text] [Related]
2. Differential Regulation of Interferon Responses by Ebola and Marburg Virus VP35 Proteins.
Edwards MR; Liu G; Mire CE; Sureshchandra S; Luthra P; Yen B; Shabman RS; Leung DW; Messaoudi I; Geisbert TW; Amarasinghe GK; Basler CF
Cell Rep; 2016 Feb; 14(7):1632-1640. PubMed ID: 26876165
[TBL] [Abstract][Full Text] [Related]
3. Impact of Měnglà Virus Proteins on Human and Bat Innate Immune Pathways.
Williams CG; Gibbons JS; Keiffer TR; Luthra P; Edwards MR; Basler CF
J Virol; 2020 Jun; 94(13):. PubMed ID: 32295912
[TBL] [Abstract][Full Text] [Related]
4. Putative endogenous filovirus VP35-like protein potentially functions as an IFN antagonist but not a polymerase cofactor.
Kondoh T; Manzoor R; Nao N; Maruyama J; Furuyama W; Miyamoto H; Shigeno A; Kuroda M; Matsuno K; Fujikura D; Kajihara M; Yoshida R; Igarashi M; Takada A
PLoS One; 2017; 12(10):e0186450. PubMed ID: 29040311
[TBL] [Abstract][Full Text] [Related]
5. Lloviu virus VP24 and VP35 proteins function as innate immune antagonists in human and bat cells.
Feagins AR; Basler CF
Virology; 2015 Nov; 485():145-52. PubMed ID: 26255028
[TBL] [Abstract][Full Text] [Related]
6. Effects of Filovirus Interferon Antagonists on Responses of Human Monocyte-Derived Dendritic Cells to RNA Virus Infection.
Yen BC; Basler CF
J Virol; 2016 May; 90(10):5108-5118. PubMed ID: 26962215
[TBL] [Abstract][Full Text] [Related]
7. Marburg virus VP35 can both fully coat the backbone and cap the ends of dsRNA for interferon antagonism.
Bale S; Julien JP; Bornholdt ZA; Kimberlin CR; Halfmann P; Zandonatti MA; Kunert J; Kroon GJ; Kawaoka Y; MacRae IJ; Wilson IA; Saphire EO
PLoS Pathog; 2012 Sep; 8(9):e1002916. PubMed ID: 23028316
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for Marburg virus VP35-mediated immune evasion mechanisms.
Ramanan P; Edwards MR; Shabman RS; Leung DW; Endlich-Frazier AC; Borek DM; Otwinowski Z; Liu G; Huh J; Basler CF; Amarasinghe GK
Proc Natl Acad Sci U S A; 2012 Dec; 109(50):20661-6. PubMed ID: 23185024
[TBL] [Abstract][Full Text] [Related]
9. Evolutionary maintenance of filovirus-like genes in bat genomes.
Taylor DJ; Dittmar K; Ballinger MJ; Bruenn JA
BMC Evol Biol; 2011 Nov; 11():336. PubMed ID: 22093762
[TBL] [Abstract][Full Text] [Related]
10. Evasion of interferon responses by Ebola and Marburg viruses.
Basler CF; Amarasinghe GK
J Interferon Cytokine Res; 2009 Sep; 29(9):511-20. PubMed ID: 19694547
[TBL] [Abstract][Full Text] [Related]
11. Mutations abrogating VP35 interaction with double-stranded RNA render Ebola virus avirulent in guinea pigs.
Prins KC; Delpeut S; Leung DW; Reynard O; Volchkova VA; Reid SP; Ramanan P; Cárdenas WB; Amarasinghe GK; Volchkov VE; Basler CF
J Virol; 2010 Mar; 84(6):3004-15. PubMed ID: 20071589
[TBL] [Abstract][Full Text] [Related]
12. Structural and functional characterization of Reston Ebola virus VP35 interferon inhibitory domain.
Leung DW; Shabman RS; Farahbakhsh M; Prins KC; Borek DM; Wang T; Mühlberger E; Basler CF; Amarasinghe GK
J Mol Biol; 2010 Jun; 399(3):347-57. PubMed ID: 20399790
[TBL] [Abstract][Full Text] [Related]
13. Development of RNA aptamers targeting Ebola virus VP35.
Binning JM; Wang T; Luthra P; Shabman RS; Borek DM; Liu G; Xu W; Leung DW; Basler CF; Amarasinghe GK
Biochemistry; 2013 Nov; 52(47):8406-19. PubMed ID: 24067086
[TBL] [Abstract][Full Text] [Related]
14. Innate Immune Responses of Bat and Human Cells to Filoviruses: Commonalities and Distinctions.
Kuzmin IV; Schwarz TM; Ilinykh PA; Jordan I; Ksiazek TG; Sachidanandam R; Basler CF; Bukreyev A
J Virol; 2017 Apr; 91(8):. PubMed ID: 28122983
[TBL] [Abstract][Full Text] [Related]
15. Crystal Structure of the Marburg Virus VP35 Oligomerization Domain.
Bruhn JF; Kirchdoerfer RN; Urata SM; Li S; Tickle IJ; Bricogne G; Saphire EO
J Virol; 2017 Jan; 91(2):. PubMed ID: 27847355
[TBL] [Abstract][Full Text] [Related]
16. Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling.
Cárdenas WB; Loo YM; Gale M; Hartman AL; Kimberlin CR; Martínez-Sobrido L; Saphire EO; Basler CF
J Virol; 2006 Jun; 80(11):5168-78. PubMed ID: 16698997
[TBL] [Abstract][Full Text] [Related]
17. The Ebola virus VP35 protein binds viral immunostimulatory and host RNAs identified through deep sequencing.
Dilley KA; Voorhies AA; Luthra P; Puri V; Stockwell TB; Lorenzi H; Basler CF; Shabman RS
PLoS One; 2017; 12(6):e0178717. PubMed ID: 28636653
[TBL] [Abstract][Full Text] [Related]
18. Sudan Ebolavirus VP35-NP Crystal Structure Reveals a Potential Target for Pan-Filovirus Treatment.
Landeras-Bueno S; Oda SI; Norris MJ; Li Salie Z; Guenaga J; Wyatt RT; Saphire EO
mBio; 2019 Jul; 10(4):. PubMed ID: 31337716
[TBL] [Abstract][Full Text] [Related]
19. Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35.
Leung DW; Prins KC; Borek DM; Farahbakhsh M; Tufariello JM; Ramanan P; Nix JC; Helgeson LA; Otwinowski Z; Honzatko RB; Basler CF; Amarasinghe GK
Nat Struct Mol Biol; 2010 Feb; 17(2):165-72. PubMed ID: 20081868
[TBL] [Abstract][Full Text] [Related]
20. Ebolavirus VP35 coats the backbone of double-stranded RNA for interferon antagonism.
Bale S; Julien JP; Bornholdt ZA; Krois AS; Wilson IA; Saphire EO
J Virol; 2013 Sep; 87(18):10385-8. PubMed ID: 23824825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]